# Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee

> **NCT05008835** · PHASE2 · TERMINATED · sponsor: **ACADIA Pharmaceuticals Inc.** · enrollment: 61 (actual)

## Conditions studied

- Osteoarthritis Pain

## Interventions

- **DRUG:** ACP-044 Dose A
- **DRUG:** ACP-044 Dose B
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05008835
- **Lead sponsor:** ACADIA Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-07-20
- **Primary completion:** 2022-10-06
- **Final completion:** 2022-11-16
- **Target enrollment:** 61 (ACTUAL)
- **Why stopped:** Study was terminated for business reasons.
- **Last updated:** 2025-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05008835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05008835, "Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05008835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*